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Abstract
Heterochromatin formation plays an important role in gene regulation and the maintenance of genome integrity. Here we
present results from a study of the D. melanogaster gene vig, encoding an RNAi complex component and its homolog vig2
(CG11844) that support their involvement in heterochromatin formation and/or maintenance. Protein null mutations vigEP812
and vig2PL470 act as modifiers of Position Effect Variegation (PEV). VIG and Vig2 are present in polytene chromosomes and
partially overlap with HP1. Quantitative immunoblots show depletion of HP1 and HP2 (large isoform) in isolated nuclei from
the vigEP812 mutant. The vig2PL470 mutant strain demonstrates a decreased level of H3K9me2. Pull-down experiments using
antibodies specific to HP1 recovered both VIG and Vig2. The association between HP1 and both VIG and Vig2 proteins
depends on an RNA component. The above data and the developmental profiles of the two genes suggest that Vig2 may
be involved in heterochromatin targeting and establishment early in development, while VIG may have a role in stabilizing
HP1/HP2 chromatin binding during later stages.
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Introduction
The nuclear content of a cell can be roughly divided into two
categories: euchromatin and heterochromatin. Euchromatin,
where most of the actively transcribed genes reside, is composed
of a relaxed array of nucleosomes with corresponding epigenetic
marks [1]. Heterochromatin, in contrast, is relatively condensed,
as a result of interactions between biochemically modified histone
tails and characteristic non-histone proteins, the components of a
repressive chromatin assembly. The most prominent heterochro-
matic mark is histone 3 di- and tri-methylation at lysine 9. This
histone modification is found in a large variety of organisms and
provides a platform for Heterochromatin Protein 1 (HP1) binding.
HP1 recognition of the H3K9 methyl mark and interactions
between the H3K9 methyltransferase Su(var)3-9 and HP1 are
thought to enable spreading of heterochromatin over significant
distances and to explain the existence of vast heterochromatic
territories at centromeres. While the interaction of HP1 and
H3K9me2/3 appears to be a consistent feature of constitutive
heterochromatin, variations on this theme may be found to
promote silencing in other contexts (reviewed in [2–4]).
The level of chromatin condensation appears to be critical for
appropriate regulation of gene expression. When a gene is moved
from its normal location to a domain with a different chromatin
density, the result is a mosaic gene inactivation, known as Position
Effect Variegation (PEV). In Drosophila several genes with visible
phenotypes, for which inactivation does not affect viability, serve
as excellent PEV reporters. Among these, the white gene is
probably the most heavily exploited. Several genetic screens using
a variegating white gene as a reporter have identified mutations
that enhance or suppress PEV. This has allowed discovery of key
structural and regulatory components of heterochromatin, includ-
ing Su(var)3-9. Additional analysis of PEV modifiers has led to an
estimate that as many as 150 genes affect chromatin-related gene
silencing [5]. However, so far only a small portion of these genes
have been thoroughly investigated.
An unanswered question is how heterochromatin formation is
targeted and maintained through cell division. In S.pombe
heterochromatin assembly at the centromere regions has been
linked to transcription of the centromeric repeats. The process of
silencing involves interactions between nascent transcripts pro-
cessed by the RNAi system and the constitutive components of
heterochromatin [6]. In this organism, an elegant ‘self-reinforcing
loop’ model explains the specificity of heterochromatin formation
based on the role of the RNAi machinery (reviewed in [7–9]).
RNA interference, discovered less than a decade ago [10], has
quickly became recognized as an important regulator of gene
expression from plants to worms and humans. Besides the
enzymatic core comprised by the protein Ago2, the RNA Induced
Silencing Complex (RISC), purified from Drosophila S2 cells,
contains dFMRP, VIG and Tudor-SN [11–13]. Mutations in ago2
and dfmr1 have been shown to affect PEV in flies, suggesting a
possible role in heterochromatin formation [14,15]. Suppression of
PEV by a gene mutation is an ‘output’ indicating that the silencing
chromatin structure is not properly formed. Questions remain as
to whether this misregulation occurs at initiation or maintenance,
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whether the gene product is physically involved in heterochromatin
formation, or whether the PEV outcome is a result of indirect effects.
The RNAi effector protein Ago2 is associated with endogenous
siRNAs targeting some transposons and protein coding genes in
germ line and somatic cells [16–18]. Another member of Argonaute
family, Piwi, is involved in piRNA generation in gonads [19]; piwi
mutations suppress PEV and Piwi protein can interact with HP1
directly [20,21]. The large majority of piRNAs (Piwi complexes) and
to a much less extent some endo siRNAs (Ago2 complexes) are
derived from transposable elements and regulate their silencing in
different compartments [16,17,22–24]. InDrosophila up to 77% of the
recently annotated 24 Mb of heterochromatic sequences are
classified as repetitive transposable elements (TEs). Among these,
the retrotransposons (LTRs and LINEs) are the largest group [25]
While much of the silencing due to RNAi is accomplished by a post-
transcriptional mechanism, it is tempting to speculate that an RNAi-
based mechanism may well be an essential part of targeting and
maintaining heterochromatic structure in flies.
Among the Ago2- RISC accessory components, VIG belongs to
a family of proteins with a recognizable RNA binding motif (the
PAI-RBP1 family) that was first identified in a HTC rat hepatoma
cell culture. Computational analyses have revealed related proteins
in other species including Homo sapiens, Drosophila melanogaster, and
Arabodopsis taliana, but not in single cell organisms [26].
The D. melanogaster genome contains three genes that encode
proteins with the PAI-RBP1 motif: VIG, CG11844 (which we will
refer to as Vig2) and CG15031 [26]. Vig (vasa intronic gene) is located
in an intron of vasa on the second chromosome and copurifies with
Ago2 in a complex containing small RNAs [12]. Mutations
disrupting vig cause up-regulation of expression from some
retrotransposons in D.melanogaster ovaries [27], suggesting the
possibility of involvement in endogenous siRNA regulation as a
member of an Ago2 complex. Defects in the antiviral responses of
vig mutant flies have also been reported [28]. In contrast very little
is known about vig2 (third chromosome) and CG15031 (X
chromosome), although CG15031 has been reported to act as a
protein phosphatase Y-interacting protein [29].
Here we examine the role of VIG and its close homolog Vig2 in
heterochromatin formation. We find that while mutations in both
genes result in suppression of PEV, it appears that the two proteins
impact heterochromatin structure through different mechanisms.
Results
Developmental expression profile of vig and vig2
VIG and Vig2 proteins are very similar in amino acid sequence
(Figure S1), suggesting possible overlapping roles. To study vig and
vig2 we generated developmental profiles of RNA and protein
levels (Figure 1). Specifically, we were interested in studying
material from the developmental stages when heterochromatin
formation occurs. Some of the genes involved in RNAi and
implicated in heterochromatin formation (piwi, homeless) are
preferentially expressed in the germline and the proteins are
maternally loaded. Heterochromatin formation begins at the
blastoderm stage at approximately 1.5 hours of embryogenesis
[30]. A model proposed by Eissenberg [31] suggests that it is stably
maintained during mitotic proliferation from mid-embryogenesis
to 3rd instar larvae, and than becomes more relaxed in the post-
mitotic period (pupal and adult stages).
We examined vig and vig2 expression in early embryos (2–4 h),
late embryos (6–18 h), larvae (2nd and 3rd instars), and adults
(somatic tissue and germline) using both real-time RT PCR and
Western blots. To detect VIG and Vig2 proteins we generated
polyclonal peptide antibodies. Anti-VIG (CSH1801) identifies a
specific band of ca 60 kDa on a Western, consistent with the
previously reported molecular weight [12]. Anti-Vig2 (CSH2542)
recognizes a protein of ca 50 kD. The specificity of the antibodies
was verified in vivo by gene knock down in Drosophila cell culture
(Figure S2). We observed differences in the expression patterns of
vig and vig2 genes (Figure 1). Vig2 is activated earlier in
development, with transcription peaking in ovaries, and accumu-
lation of the protein in the germline and early embryo. Later the
gene is transcribed at lower levels and the amount of protein
declines. VIG is also present in the ovaries and early embryos, but
transcription peaks at the late embryonic stage; protein accumu-
lation starts in the late embryo and reaches its maximum amount
in larvae, when the amount of Vig2 is reduced. While VIG protein
is still present in adult somatic tissue, Vig2 is not detected.
Cellular localization of VIG and Vig2
For better functional characterization we performed a partial
purification of VIG and Vig2 proteins from nuclear and
Figure 1. A developmental profile of expression of the vig and
vig2 genes generated using quantitative real-time RT PCR and
Western immunoblotting. (A) Vig and vig2 are transcriptionally
active throughout development reaching the highest levels in ovaries
(vig2) and in larvae (vig). Vig and CG11844 expression levels shown are
normalized to the expression of the RpL32 gene. (B) VIG protein can be
detected at all stages of development and in somatic as well as in
germline tissue (Western blot using CSH1801). Significant protein
accumulation occurs in late embryogenesis and at the larval stage. Vig2
protein is at its highest levels in ovarian tissue and early embryos, but is
present throughout development; the amount of protein gradually
declines and becomes undetectable in adult soma (Western blot using
CSH2542). H2B antibodies were used for the loading control.
doi:10.1371/journal.pone.0006182.g001
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cytoplasmic material of Drosophila S2 cells. We found both
proteins in nuclear and in cytoplasmic extracts (Figure 2). These
results suggest that VIG and Vig2 function both in the nucleus
and in the cytoplasm. The broad peak of VIG and of Vig2 in the
nuclear and cytoplasmic fractions suggests that in each
compartment these proteins are likely to be associated with
other factors in complexes of different sizes and possibly of
different functions.
Figure 2. Recovery of VIG and Vig2 from nuclear and cytoplasmic S2 cell extracts. (A) Nuclear and cytoplasmic material was subjected to
Superose-6 column chromatography. The numbers above the Western image represent different fractions. Peaks of size standards used to calibrate
the column are shown. The Western blot was performed using an antiserum that recognizes both VIG1 and Vig2 (CSH1803). (B) Segregation of
nuclear and cytoplasmic components in the extracts used for column chromatography is verified by a control Western blot for HP1 (nuclear) and
Dynein (cytoplasmic).
doi:10.1371/journal.pone.0006182.g002
VIG and Vig2 Impact Chromatin
PLoS ONE | www.plosone.org 3 July 2009 | Volume 4 | Issue 7 | e6182
Vig and vig2 mutations are modifiers of variegation
The PEV system provides a very sensitive assay for the
involvement of candidate genes in heterochromatin formation.
In this study we used yellow variegating reporters located in regions
57h (B79) and 49h (J545) of chromosome 3, and within centric
region 10h of chromosome Y (J448) [32,33] to evaluate the ability
of vig and vig2 mutations to affect PEV. The vigEP812 mutation is
caused by a P{EP} insertion within the vig coding region (Figure
S3A) that results in severe reduction of the VIG protein
(Figure 3A). PBac{GAL4D,EYFP} resides in the vig2 gene [34]
and disrupts the production of Vig2 protein (Figure 3B). We
generated flies carrying the yellow PEV reporters and mutations in
either vig or vig2:
y1w67c23/Y; vigEP812/+; P(y+)B79/+
y1w67c23/Y; +; P(y+)B79/vig2PL470
y1w67c23/Y; vigEP812/+; P(y+)J545/+
y1w67c23/Y; +; P(y+)J545/vig2PL470
y1w67c23/Y, P(y+)J448; vigEP812/+; +
y1w67c23/Y, P(y+)J448; +; vig2PL470/+.
To score the variegating yellow phenotype we prepared male
abdominal cuticles and compared the number of dark patches to
the WT control. The control flies were obtained simultaneously in
a separate cross between males carrying the reporter and y1w67c23
females (for example: y1w67c23/Y; +; P(y+)B79/+). (This control
cross is necessary because it is inappropriate to use siblings
carrying the PEV reporter and a balancer chromosome as a WT
control, as the balancer chromosomes often carry modifiers of
PEV). However, the vigEP812 mutation affects the vasa gene as well
as vig (Figure S3A), and any suppression of PEV in this case could
be attributed to the deficit in Vasa protein. To resolve this issue we
crossed a stock carrying the yellow PEV reporter P(y+)B79/+ and
the vasaAS mutant line (Figure S3A), in which only the vasa gene is
affected [35] and vig expression is at wild type level (Figure S3B).
Analysis of the progeny phenotype demonstrated that the vasaAS
mutation does not modify PEV (Figure S3C), indicating that the
suppression observed with the vigEP812 mutation is caused by a
reduction in the levels of VIG.
Silencing of the yellow reporter B79 was relieved in a vigEP812 or
vig2PL470 heterozygote mutant background (Figure 3C, panels 1–
3). The J545, reporter located in a different heterochromatic
domain, was not sensitive to the vigEP812 mutation; but vig2PL470
resulted in enhancement of variegation (Figure 3C, panels 4–6).
The J448 P-element is inserted in the centric region of the Y
chromosome; flanking sequences include 1360 and Su(Ste). Both
vigEP812 or vig2PL470 mutations caused suppression of variegation at
this location (Figure 3C, panels 7–9). The differences seen with
various PEV reporters are not without precedent; Su(var)3-9
mutations result in suppression of variegation for reporters in the
pericentric heterochromatin, but enhancement of variegation for
reporters in the fourth chromosome [36,37]. Overall, the results of
the yellow PEV tests suggest an involvement of VIG andVig2 proteins
in heterochromatin formation or maintenance. However, the PEV
reporters’ readouts indicate that VIG and Vig2, unlike HP1, are not
heterochromatin ‘construction material’; our data suggest that vig2
gene is rather involved in targeting (nucleation) of heterochromatic
domains. Mutations in this gene may cause the disruption of proper
distribution of heterochromatin structural components; as a result we
observe suppression or enhancement of variegation. One can
speculate that Vig2 is epistatic to VIG in this process. Vig2 is
prominent in the early embryo, when heterochromatin formation is
initiated, whileVIG is expressed at higher levels in larval stages, when
heterochomatin formation must be maintained.
VIG and Vig2 partially overlap with HP1 on polytene
chromosomes
Large polytene chromosomes are found in the larval salivary
glands of Drosophila. Immunostaining of these chromosomes with
antibodies allows detection and analysis of the distribution pattern
of any nuclear protein in vivo. HP1 stains predominantly the
chromocenter, telomeres, and the small 4th chromosome, the
domains where most of the heterochromatin is found. In addition,
HP1 also marks numerous sites on the chromosome arms, including
the ‘goose neck’, a cluster of bands on the 2nd chromosome [38],
and large puffs (sites of intense transcription) [39].
To visualize the distribution of VIG and Vig2 relatively to HP1
we treated WT polytene chromosomes with antibodies generated
against the C-terminus of VIG (CHS1803) and a mouse monoclonal
antibody specific for HP1 (C1A9) (Figure 4A). CHS1803 recognizes
both VIG and Vig2; it was used in preference to other VIG
antibodies because of its high sensitivity and the absence of cross-
reacting bands on a Western blot using total protein from salivary
glands (Figure S4). The CSH1803 antiserum stains the chromo-
center and produces a complex pattern on the chromosome arms.
Figure 4A shows the overlap between HP1 signal and the signal
produced by CSH1803 at the chromocenter (arrow 1) and at some
sites on chromosome arms. Only partial overlap is observed; for
example, the ‘goose neck’ region, prominently associated with HP1,
is devoid of both VIG and Vig2 (arrow 3). Among numerous sites on
the chromosomal arms marked by CSH1803, only some are shared
with HP1 (arrow 2). To obtain the individual distribution patterns of
VIG and Vig2, we used salivary glands from homozygous vigEP812 or
vig2PL470 mutant larvae, after having verified by immunoblot
(Figure 4B) that in the absence of VIG only Vig2 is recognized by
this antibody and vice versa. The distribution pattern of Vig2 seen
on vigEP812 polytene chromosomes (Figure 4C) clearly shows overlap
between HP1 and Vig2 at the chromocenter and at some sites on
the chromosome arms, including sites of active transcription (large
puffs). By contrast, VIG staining of vig2PL470 chromosomes presents
different features (Figure 4D). There is little signal present at the
chromocenter and intense staining is seen at scattered sites on the
chromosome arms, including some large puffs where HP1 is also
present. Thus, VIG localization on polytene chromosomes differs
from that of Vig2. In particular, Vig2 association with constitutive
heterochromatin domains suggests that this protein could be
involved in heterochromatin formation and/or maintenance. On
the other hand, VIG overlaps with HP1 primarily at some sites on
the chromosome arms, including puffs, suggesting either a direct
role in heterochromatin formation or participation in regulatory
processes that have indirect effects on heterochromatin.
The H3K9me2 level is decreased in the vig2PL470 mutant,
but not in vigEP812
To further investigate the role that VIG and Vig2 play in the
process of heterochromatin formation, we looked at the hallmark
of silent chromatin - H3K9 dimethylation. We prepared protein
extracts from adult flies and assessed the level of H3K9me2 by
quantitative Western blot (Figure 5). For reference we used the
H3K9me2 levels of the Oregon R (WT) strain and the Su(var)3-906
mutant flies. The Su(var)3-9 gene encodes one of three known
histone H3K9 methyltransefases in Drosophila, and is an effective
suppressor of PEV. Su(var)3-906 is a null allele in which H3K9me2
levels are significantly decreased in embryos [40]. In adult flies the
dimethylation of H3K9 in a homozygous Su(var)3-9 mutant
background fell by ca. 50% relatively to WT. The homozygous
vigEP812 mutant did not show any loss of H3K9 methylation, but
the homozygous vig2PL470 mutant clearly demonstrated a decrease
VIG and Vig2 Impact Chromatin
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Figure 3. Vig and vig2 mutants are dominant modifiers of PEV. (A, B) VIG and Vig2 production is disrupted in mutant lines as shown by
Western analysis. VigEP812 is a P-element insertion in the coding region of vig; vig2PL470 is a piggyBac-based insertion in vig2. Protein extracts from adult
flies homozygous for these mutations were used as starting material. (C) Examination of the yellow variegating reporters B79, J545, and J448 in a vig
or vig2 haplo deficient background. Bar graphs represent the number of pigmented patches on males’ dissected abdomens normalized to the control
(set at 1). Error bars indicate standard errors. Typical images of the observed phenotypes are shown above the graph.
doi:10.1371/journal.pone.0006182.g003
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to ca. 60% of WT levels. We also checked different types of tissues.
Adult heads (soma) and ovaries (germline) both exhibit the same
pattern of H3K9me2 depletion as seen in whole adult flies (Figure
S5). In conclusion, while both vig and vig2 mutants can be
dominant suppressors of PEV, these experiments show that vig2
impacts H3K9 methylation, a key signature of heterochromatin,
while vig does not.
HP1 and HP2 (Large isoform) are depleted in the nuclei
of a vig mutant
Next we extended our analysis to another major component of
heterochromatin, the HP1 protein. Nuclear proteins were
extracted from adult tissues of the same fly strains: Oregon R
(WT), vigEP812, vig2PL470, and Su(var)3-906. Because prior studies
have shown that in homozygous Su(var)3-906 mutant larvae HP1 is
Figure 4. Immunofluorescent staining of polytene chromosomes. (A) VIG and Vig2 (visualized using CSH1803) show a distribution pattern
that overlaps with HP1 at the chromocenter (arrow 1) and in some cases on the chromosome arms (arrow 2) of the WT polytene chromosomes.
However, the majority of the cytobands do not overlap; for instance, region 31 on the 2nd chromosome (the ‘goose neck’) is associated with HP1
alone (arrow 3). The lower row of images shows staining at the chromocenter. (B) Western blot performed using protein from salivary glands shows
detection of both VIG and Vig2 protein by the CSH1803 antibody. In the vigEP812 mutant only Vig2 is present; in the cg11844PL470 mutant only VIG is
recognized. (C) Polytene chromosomes were obtained from vigEP812 mutant larvae; in the absence of VIG we observe significant overlap between HP1
and Vig2 protein at the chromocenter and at some sites on the chromosome arms. The lower row of images shows staining at the chromocenter. (D)
The distribution of VIG seen on vig2PL470 mutant polytene chromosomes shows multiple overlapping sites shared by HP1 and VIG on the
chromosomal arms, but only faint speckles of VIG at the chromocenter. The lower row of images shows staining at the chromocenter.
doi:10.1371/journal.pone.0006182.g004
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lost from the chromocenter of polytene chromosomes, we used this
mutant line as a positive control [41]. As expected, quantitative
Western blots show a loss of nuclear HP1 in Su(var)3-906 mutants.
Similarly, we detected only about 50% of the WT level of HP1 in
the homozygous vigEP812 mutant line, but we did not see any
changes in homozygous vig2PL470 flies (Figure 6A). We considered
the possibility that the vig mutation could affect the expression of
Su(var)205 (most likely indirectly) and tested Su(var)205 RNA levels
by RT-PCR. However, there were no changes in a comparison to
the levels of Su(var)205 messenger RNA in WT and vigEP812
mutants (Figure S6). To further verify the HP1 results, we looked
at a binding partner of HP1, Heterochromatin Protein 2 (HP2)
[42,43]. The Su(var)2-HP2 gene codes for two HP2 protein
isoforms, HP2 Large (HP2L) and HP2 Small (HP2S); HP2L
binding to heterochromatin is HP1-dependent. We estimated the
amount of HP2L in nuclei by quantitative Western blot
(Figure 6B). The results obtained for HP2L were reflective of
HP1: loss of HP2L was observed in nuclei prepared from vigEP812
and Su(var)3-906 mutant flies, but not in those from the vig2PL470
line. These results suggest that VIG might be involved in
stabilizing the interaction of HP1 with chromatin, while Vig2
does not play such a role. The latter result is surprising, given that
the Vig2 mutation has an effect on H3K9 methylation.
HP1, VIG and Vig2 co-immunoprecipitate
To examine whether VIG or Vig2 are present in a complex
with HP1 we performed immunoprecipitation experiments using
antibodies specific for HP1 (C1A9 and WA191), VIG (CSH1801),
and Vig2 (CSH2542). In addition to co-precipitating HP2L, as
expected, HP1 also co-precipitated VIG and Vig2 (Figure 7A).
Similarly anti-VIG and anti-Vig2 antibodies pulled down both
HP1 and HP2L (Figure 7B). Because VIG and Vig2 contain RNA
binding domains, we tested whether these interactions with HP1
Figure 5. Quantitative Western blot for H3 dimethylation at
Lys9. Total protein extracts were obtained from adult flies and probed
with an anti-H3K9me2 specific antibody; anti-H4 was used as a loading
control. A stock carrying a null mutation of Su(var)3-9 histone
methyltransferase was used as a control. Vig2PL470 demonstrates a
diminished level of H3K9me2, whereas vigEP812 does not. Error bars
represent standard error of the mean.
doi:10.1371/journal.pone.0006182.g005
Figure 6. Quantitative Western blots to estimate the amounts
of HP1 and HP2 in adult fly nuclear preparations. (A) The vigEP812
strain shows a decrease in HP1 similar to the Su(var)3-906 mutant. In
vig2PL470 flies the level of HP1 appears to be similar to WT. H4 was used
as a loading control. (B) The HP2 Large isoform follows the HP1 pattern.
Actin served as a loading control. Error bars represent standard error of
the mean.
doi:10.1371/journal.pone.0006182.g006
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were dependent on an RNA component. Indeed, treatment with
RNase A prior to immunoprecipitation with anti-HP1 antibodies
resulted in loss of signal, suggesting that the HP1/ VIG and HP1/
Vig2 interactions are RNA dependent.
Discussion
We have presented new results suggesting the involvement of
the RNAi-associated protein VIG, and its homolog Vig2, in
heterochromatin formation. VIG and Vig2 belong to the PAI-
RBP1 family. Based on DNA sequence and protein database
analyses, one can infer that these proteins play a role in mRNA
stability and/or in processes requiring interactions with RNA [26].
Human paralogs of VIG, SERBP1 and HABP4, have been
reported to localize in the cell cytoplasm, nucleus, and perinuclear
regions; our data indicate that VIG and Vig2 are both nuclear and
cytoplasmic (Figure 2). Human VIG paralogs interact with the
silencing chromatin remodeling complex CHD3, as shown by a
yeast two-hybrid screen [44]. Our data expand the proposed role
of PAI domain proteins in chromatin regulation by demonstrating
that deficits in VIG and Vig2 can result in suppression of PEV
(Figure 3). We observe both in vivo co-localization (Figure 4) and
evidence of interaction (Figure 7) with major components of
repressive chromatin, HP1 and HP2.
It has recently been reported that in Drosophila, HP1 binding
and H3K9 methylation in heterochromatin are dependent on
physical interaction with ‘inactive’ (unphosphorylated) STAT [45].
This is a surprising connection, since canonical JAK/STAT
regulation pathways have been thought of as generally involved in
transcription regulation. VIGs’ human paralog SERBP1 interacts
with Protein Inhibitor of Activated STAT (PIAS) [46], which has
its own fly paralog encoded by the Su(var)2-10 gene [47]. These
pieces of information suggest an interpretation of our results. Our
data demonstrate that VIG is involved in stabilization of HP1
binding to chromatin (Figure 6) and that Vig2 affects H3K9me2
levels (Figure 5). Considering the findings discussed above, one can
speculate that in Drosophila VIG and Vig2 might function in
concert with components of the JAK/STAT pathway or a non-
canonical STAT pathway to modulate heterochromatin forma-
tion. In particular, RNA binding proteins such as VIG, perhaps
collaborating with Su(var)2-10, a PIAS protein, could potentially
facilitate binding of inactive STAT and consequently HP1 to
heterochromatic domains. The Drosophila JAK/STAT pathway
has an important role in the immune response, particularly in viral
defense [48], a process also related to RNAi. Our results indicate
that the association between VIG or Vig2 and HP1 is RNA
dependent. One can speculate that transcripts originating from
transposable elements (a major sequence component of hetero-
chromatin), processed by the RNAi machinery, could be the
constituents of a targeting complex containing HP1. VIG has been
demonstrated to interact with small RNAs in Drosophila S2 cells.
The human paralog of VIG has been shown to interact with L1
retrotransposon products in the stress granules and to participate
in regulation of retrotransposition together with other RNAi
components, including Ago2 and FMRP [49]. However, Drosophila
VIG and Vig2 -interacting RNAs have yet to be identified and
characterized.
Many unanswered questions still remain. Why do deficits of
either VIG or Vig2 have such different impacts on HP1 nuclear
binding and H3K9 methylation? Many previous studies have
Figure 7. Co-immunoprecipitation experiments show the
association of heterochromatin structural proteins HP1 and
HP2 with the RNA-interacting proteins VIG and Vig2. (A) The
HP1 monoclonal antibody C1A9 pulls down HP2 large isoform (as
expected) and both VIG and Vig2 proteins. Mouse IgG was used for the
control mock immunoprecipitation. (B) Antibodies specific for VIG
(CSH1801) and Vig2 (CSH2542) proteins pull down HP2 Large isoform
and HP1. Rabbit IgG was used as a negative control. (C) RNaseA
treatment of the homogenates reduces the amount of VIG and Vig2
protein pulled down by the HP1 antibody. Mouse IgG was used for the
control mock immunoprecipitation.
doi:10.1371/journal.pone.0006182.g007
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shown that HP1 binding and H3K9 methylation are interdepen-
dent [40]. However, detailed analyses of HP1 distribution using
cytoimmunochemical approaches and high resolution mapping
based on the DamID technique have shown that although HP1
and the H3K9me2 mark generally overlap in the chromocenter
and pericentric regions, there are also numerous sites on the
chromosome arms where HP1 binding is not associated with di- or
trimethylation of H3K9. In some cases this binding is dependent
on RNA [39,50,51]. Our cytological results indicate that VIG and
HP1 overlap mostly outside of the chromocenter, including sites of
active transcription (Figure 4D). Destabilization of HP1 binding in
those locations seems unlikely to result in significant overall
changes in H3K9me levels. The HP1/VIG immunosignals could
mark sites of endogenous small RNA precursors and could be
involved in regulatory processes affecting heterochromatin indi-
rectly.
In the Su(var)205 mutant, the resulting HP1 deficit does not
result in loss of H3K9 methylation; Su(var)3-9 HKMTase and
H3K9me2 are still present at the chromocenter, but are also found
in euchromatin, resulting in an almost ubiquitous distribution of
H3K9me2 [41]. This suggests that HP1 is probably not the only
protein involved in tethering HKMTases to chromatin, although a
role for HP1 in sequestering H3K9 methylation to heterochro-
matin is clear [52]. Therefore our results showing that vig mutation
causes HP1 destabilization without an effect on H3K9 methylation
level is not without precedent.
The developmental profile generated for vig and vig2 expression
shows that the two genes have activity peaks at different stages of
development. Vig2 is very abundant in ovaries, where several
different HKMTases (dSETDB1, Su(var)3-9, and G9a) work
together to methylate H3K9 [53–55]. Depletion of Vig2 results in
a decreased level of H3K9me2 in adult flies; however, there was
no effect on the amount of HP1 observed in the nuclei. Of the
three HKMTases, only Su(var)3-9 is known to recruit HP1
molecules directly, while the others utilize alternative mechanisms,
yet to be identified. The point of intersection with Vig2 remains to
be identified.
Despite the differences in their action, both VIG and Vig2
appear to be new components of an extensive network embracing
heterochromatin, small RNAs and transcription regulation.
Studying the specific functions of VIG and Vig2 in detail will be
important in understanding the dynamics of heterochromatin
establishment and maintenance.
Materials and Methods
Fly strains and genetic experiments
Fly stocks were maintained at 22uC, 70% humidity on a
cornmeal sucrose-based medium [56]. The w*;P{EP}vigEP812/CyO
stock was obtained from the Szeged Drosophila Stock Centre;
homozygous mutant flies are viable, females are sterile. w*; P
{FRT(whs)}2A P{neoFRT}82B PBac{GAL4D,EYFP}CG11844PL00470
(vig2PL470) was obtained from the Bloomington Drosophila Stock
Center (BL #19518); homozygous mutant flies are viable and
fertile. vasAS is described in [35]. X chromosomes of the above
mentioned lines were replaced by the y w chromosomes. In the
vigEP812/CyO stock the 2nd chromosome balancer was changed to
CyO, P{w+mC GAL4}, P{w+mC UAS-GFP} for polytene chromosome
immunofluorescence experiments. w; Su(var)3-906 has been
described elsewhere [57]. The PEV reporters B79, J545, J448
have been characterized previously [32,33].
To assess modification of PEV, genetic crosses were conducted
as follows: virgin females carrying the mutation of interest
(y1w67c23; vigEP812/CyO, or y1w67c23; vig2PL470, or y1w67c23; vasAS/
CyO) or ‘wild type’ y1w67c23 flies were crossed to males carrying the
PEV reporters y1/Y; +; P(y+)B79, y1/Y; +; P(y+)J545, y1/Y,
P(y+)J448; +; +. Male progeny from WT and mutant mothers
were compared.
Adult abdominal cuticle preparation
Flies were immobilized on the adhesive side of a piece of tape
and covered with PBST. The abdomens were sliced off, dissected
along the dorsal midline, and cleaned. These abdomen cuticle
halves were transferred to a drop of mounting media [Shandon
Immu-Mount (Thermo Fisher Scientific) supplemented with
chloral hydrate (53% v/v) and lactic acid (9% v/v)], spread on a
microscope slide, covered by a cover slip, left to dry overnight on
the slide warmer at 42uC, and subsequently photographed.
Real time RT-PCR
RNA was extracted using TRIzol Reagent (Invitrogen)
according to the manufacturer’s recommendations. For quantita-
tive real time one-step RT-PCR we used the QuantiTect RT-PCR
Kit (Qiagen), following the instructions provided by the manufac-
turer for the SmartCycler PCR machine (Cepheid). Standard
curves were generated using 0.5–500 ng of total RNA for each
primer pair. The expression level of the RpL32 gene was used for
normalization.
Primers used: Su(var)205 (HP1): ACCATTTCTGCTTGGTC-
CAC and CAAGCGAAAGTCCGAAGAAC; vig: TTCGCT-
GTCGTTCTCCTTCTCCTTCT and AAAGAGCTGACCT-
TGGACGA; vig2: GCGTCAATTCAACAATCGTG and CCC-
GGTCGTCTTTAAGTCCT; RpL32: ATGGTGCTGCTATC-
CCAATC and GTCGCCTGCGTTCTCAAG.
Antibodies
Rabbit polyclonal antisera directed against the N-terminal 10–
14 AA of VIG and Vig2, CSH1801, CHS1803, and CSH2542
were raised as previously described [11]. Anti- HP1 [38] anti-HP1
(WA191 [58]), anti-Vasa (Lasko and Ashburner, 1990) and anti-
HP2 [59] have been previously described. Anti-H2B (# 07–371);
anti-H3K9me2 (# 07–441); anti-H4 (# 07–108) were purchased
from Upstate; anti-Actin (JLA20) was obtained from DSHB; anti-
Dynein was purchased from Sigma (D5167).
Secondary HRP-conjugated antibodies were purchased from
Thermo Scientific.
Polytene chromosomes squashes and immunostaining
Polytene chromosomes were prepared as described [60]. VIG
deficient 3rd instar larvae were selected based on the absence of
fluorescence from vigEP812/ CyO, P{w+mC GAL4}, P{w+mC UAS-
GFP} stock. HP1 distribution patterns were identified using the
C1A9 monoclonal antibody diluted 1:10. VIG and Vig2 were
detected using the CSH1803 antibody at a 1:5 dilution. Secondary
antibodies (Molecular Probes) were labeled with Alexa Fluor 594
(red) and Alexa Fluor 488 (green). The images of HP1 and VIG or
Vig2 distribution were captured simultaneously (Figure 4, colored
panels); then red and green color channels were separated using
Corel PHOTO-PAINT software to create the black and white
images of HP1, VIG, and Vig2 individual distributions.
Western analysis
Total protein extracts were obtained as follows: 3–4 day old flies
were collected, ground in 10 mM Tris pH 8 with ‘Complete’
Protease Inhibitor Cocktail (Roche), and left on ice for 309. 26
Laemmli loading buffer (LLB) (BioRad) was added and the
mixture boiled for 5 min. Nuclei were prepared as described
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previously [58]. Nuclear material was sheared using a syringe (22–
24G needle) and the homogenate boiled in LLB for 5 min. At least
3 independent protein extractions were performed for each
experiment. Extracted proteins were size separated by SDS-
PAGE, transferred to a nitrocellulose membrane (Protran, What-
man) and probed with the antibody of interest in 2.5% milk TBS-
T overnight at 4uC. The antibodies were diluted as follows: anti-
VIG (CSH1801) 1:5,000; anti-Vig2 (CSH2542) 1:20,000; anti-
VIG (CSH1803) 1:10,000; anti-H2B 1:10,000; anti-H3K9me2
1:20,000; anti-H4 1:2,000; anti-HP1 1:100; anti-HP1 (WA191) 1:
2,000; anti-HP2 1:10,000; anti-Actin 1:500; anti-Vasa 1:5,000;
anti-Dynein 1:2,000. Secondary goat anti-rabbit (or mouse) HRP-
conjugated antibodies were diluted as 1:100,000–500,000. Super-
Signal West Femto Maximum Sensitivity Substrate (Thermo
Scientific) was used for detection. Quantitative data was obtained
as follows: gradually increasing amounts of the protein extract
were loaded in successive lanes for all genotypes and probed with
the corresponding antibodies as described above. Densitometry
measurements of this dilution series showed that the antibodies
applied were sensitive to the dosage of the proteins and that the
optical signal response was linear in this range. ‘Standard curves’
showing the optical value dependence on the amount of loaded
protein for the WT sample were generated for the protein of
interest and for the loading control protein. Using these standard
curves we determined the relative amount of proteins in the
mutant lines. The bar graphs represent the ratio between the
protein of interest and the loading control. (Note that because the
two antibodies (one specific for the protein of interest and the other
for the loading control) demonstrate different sensitivities and
different response curves, it is not appropriate to use un-calibrated
optical data for quantitation.)
Purification of VIG and Vig2 from nuclear and
cytoplasmic S2 cell extracts
S2 cells were harvested, washed twice in PBS, resuspended in
buffer A (10 mM Hepes pH 7.9, 1.5 mM MgCl2, 10 mMKCl,
1 mM DTT), and protease inhibitors (Roche) and lysed in ice for
309. Cells were then disrupted in a Dounce homogenizer with the
B pestle for 40 strokes and spun at 800 g for 209. The supernatant
was collected and clarified at 20,000 g for 309; this is the
cytoplasmic fraction. The pellet from the 800 g spin was
resuspended in a small amount of buffer A plus 2 mM CaCl2
and treated with Turbo DNAseI (Ambion) for 29 in a 37uC water
bath with shaking. The nuclei were then spun down briefly and
resuspended in buffer B (20 mM Hepes pH 7.9, 40 mM NaCl,
1.5 mM MgCl2, 20 v/v glycerol, 0.2 mM EDTA), and agitated
for 309 at 4uC. The nuclear extract was then homogenized and
clarified by spinning at 20,000 g for 309. The supernatant is the
nuclear fraction. The pellet was then sonicated in SDS loading
buffer to obtain a chromatin fraction. Both cytoplasmic and
nuclear extracts were filtered through 0.4 micron and 0.8 micron
filters, respectively.
AKTA FPLC was used for Superose- 6 column chromatogra-
phy [12,61]. Two mls of nuclear and cytoplasmic extracts (20–
35 mg/ml) were filtered through a 0.4/0.8 micron filter, loaded
onto a Sepharose 6 column (Amersham Biosciences) and eluted
with 1.2 column volumes of buffer A9 (100 mM NaCl instead of
10 mM KCl). 10 ul from each fraction were boiled with SDS
sample buffer for 5 minutes and loaded onto a 10% SDS-PAGE.
Immunoprecipitation experiments
Whole flies or ovaries were ground in Lysis Buffer (20 mM Tris
pH 7.5, 100 mM NaCl, 0.5 mM EDTA pH 8, 0.5% NP40,
‘Complete’ Protease Inhibitor Cocktail (Roche)). Fly homogenates
were filtered through 1 layer of Miracloth (Calbiochem).
Preclearing step: 50 ul of Protein A/G beads (Thermo Scientific)
previously washed in Lysis Buffer were added to 500 ul of fly
homogentate and the mixture was incubated on a rocking
platform for 30 min at 4uC; the beads were collected by
centrifugation (2 min at 500 g) and the liquid phase was
recovered. The aliquot taken at this step served as the ‘input’
sample. 5 ug of the antibodies or purified IgG (Jackson
ImmunoResearch) was added to the homogenates and the
mixtures were incubated on a rocking platform for 2 h at 4uC;
then 50 ul of Protein A/G beads were added and incubation
continued for 1 h at 4uC. The beads were spun down and washed
3 times with Lysis Buffer. The antibodies and immunoprecipitated
material were released from the beads by boiling in 50 ul of LLB
for 5 min; the proteins were analyzed by Western blot.
RNase treatment of extracts was conducted as outlined [62].
RNase A (100 ug/ml final concentration) was added to the
precleared extracts before immunoprecipitation and the rest of
procedure was performed as described above.
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